AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Nam, RK Toi, A Vesprini, D Ho, M Chu, W Harvie, S Sweet, J Trachtenberg, J Jewett, MAS Narod, SA
Citation: Rk. Nam et al., V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression, UROLOGY, 57(1), 2001, pp. 199-204

Authors: Vesprini, D Nam, RK Trachtenberg, J Jewett, MAS Tavtigian, SV Emami, M Ho, M Toi, A Narod, SA
Citation: D. Vesprini et al., HPC2 variants and screen-detected prostate cancer, AM J HU GEN, 68(4), 2001, pp. 912-917

Authors: Nam, RK Diamandis, EP Toi, A Trachtenberg, J Magklara, A Scorilas, A Papnastasiou, PA Jewett, MAS Narod, SA
Citation: Rk. Nam et al., Serum human glandular kallikrein-2 protease levels predict the presence ofprostate cancer among men with elevated prostate-specific antigen, J CL ONCOL, 18(5), 2000, pp. 1036-1042

Authors: Nam, RK Elhaji, Y Krahn, MD Hakimi, J Ho, M Chu, W Sweet, J Trachtenberg, J Jewett, MAS Narod, SA
Citation: Rk. Nam et al., Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression, J UROL, 164(2), 2000, pp. 567-572

Authors: Nam, RK Redelmeier, DA Spiess, PE Sampson, HA Fradet, Y Jewett, MAS
Citation: Rk. Nam et al., Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis, J UROL, 163(3), 2000, pp. 752-757

Authors: Zini, A Nam, RK Mak, V Phang, D Jarvi, K
Citation: A. Zini et al., Influence of initial semen quality on the integrity of human sperm DNA following semen processing, FERT STERIL, 74(4), 2000, pp. 824-827

Authors: Vassilikos, EJK Yu, H Trachtenberg, J Nam, RK Narod, SA Bromberg, IL Diamandis, EP
Citation: Ejk. Vassilikos et al., Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up, CLIN BIOCH, 33(2), 2000, pp. 115-123

Authors: Nam, RK Fleshner, N Rakovitch, E Klotz, L Trachtenberg, J Choo, R Morton, G Danjoux, C
Citation: Rk. Nam et al., Prevalence and patterns of the use of complementary therapies among prostate cancer patients: An epidemiological analysis, J UROL, 161(5), 1999, pp. 1521-1524
Risultati: 1-8 |